{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:43:47Z","timestamp":1793774627401,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"State of Texas Rare and Aggressive Breast Cancer Research Program Grant"},{"name":"Morgan Welch Inflammatory Breast Cancer Research Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1245\/s10434-022-12142-7","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T18:03:06Z","timestamp":1658253786000},"page":"6370-6378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment"],"prefix":"10.1245","volume":"29","author":[{"given":"Clara R.","family":"Farley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo","family":"Adesoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie X.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"DeSnyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona F.","family":"Shaitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward I.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mediget","family":"Teshome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"12142_CR1","doi-asserted-by":"publisher","unstructured":"Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, Cormier JN. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015;65(1):55\u201381. doi:https:\/\/doi.org\/10.3322\/caac.21253. Epub 2014 Nov 19. Review.","DOI":"10.3322\/caac.21253"},{"issue":"10","key":"12142_CR2","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.31557\/APJCP.2019.20.10.3077","volume":"20","author":"DSP Josephine","year":"2019","unstructured":"Josephine DSP. Evaluation of lymphedema prevention protocol on quality of life among breast cancer patients with mastectomy. Asian Pac J Cancer Prev. 2019;20(10):3077\u201384. https:\/\/doi.org\/10.31557\/APJCP.2019.20.10.3077.","journal-title":"Asian Pac J Cancer Prev."},{"key":"12142_CR3","doi-asserted-by":"publisher","unstructured":"Pusic AL, Cemal Y, Albornoz C, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv. 2013;7(1):83\u201392. doi: https:\/\/doi.org\/10.1007\/s11764-012-0247-5. Epub 2012 Dec 5. Review.","DOI":"10.1007\/s11764-012-0247-5"},{"issue":"7","key":"12142_CR4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","volume":"16","author":"RJ Tsai","year":"2009","unstructured":"Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16(7):1959\u201372. https:\/\/doi.org\/10.1245\/s10434-009-0452-2 (Epub 2009 Apr 14).","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"12142_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/annonc\/mdq345","volume":"22","author":"S Dawood","year":"2011","unstructured":"Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22(3):515\u201323. https:\/\/doi.org\/10.1093\/annonc\/mdq345 (Epub 2010 Jul 5).","journal-title":"Ann Oncol."},{"key":"12142_CR6","doi-asserted-by":"publisher","unstructured":"Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH. Epidemiology of inflammatory breast cancer (IBC). Breast Dis. 2005\u20132006;22:9\u201323. doi: https:\/\/doi.org\/10.3233\/bd-2006-22103. Review.","DOI":"10.3233\/bd-2006-22103"},{"issue":"1","key":"12142_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590 (Epub 2020 Jan 8).","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"12142_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/cancers2010143","volume":"2","author":"PH Levine","year":"2010","unstructured":"Levine PH, Zolfaghari L, Young H, et al. What is inflammatory breast cancer? Revisiting the case definition. Cancers (Basel). 2010;2(1):143\u201352. https:\/\/doi.org\/10.3390\/cancers2010143.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"12142_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.prro.2019.05.011","volume":"9","author":"SR Stecklein","year":"2019","unstructured":"Stecklein SR, Rosso KJ, Nuanjing J, et al. Excellent locoregional control in inflammatory breast cancer with a personalized radiation therapy approach. Pract Radiat Oncol. 2019;9(6):402\u20139. https:\/\/doi.org\/10.1016\/j.prro.2019.05.011 (Epub 2019 May 24).","journal-title":"Pract Radiat Oncol."},{"key":"12142_CR10","doi-asserted-by":"publisher","unstructured":"Ueno NT, Espinosa Fernandez JR, Cristofanilli M, et al. International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer. 2018;9(8):1437\u201347. doi: https:\/\/doi.org\/10.7150\/jca.23969. eCollection 2018.","DOI":"10.7150\/jca.23969"},{"issue":"3","key":"12142_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/COC.0b013e3182937921","volume":"38","author":"CJ Tsai","year":"2015","unstructured":"Tsai CJ, Li J, Gonzalez-Angulo AM, et al. Outcomes after multidisciplinary treatment of inflammatory breast cancer in the era of neoadjuvant HER2-directed therapy. Am J Clin Oncol. 2015;38(3):242\u20137. https:\/\/doi.org\/10.1097\/COC.0b013e3182937921.","journal-title":"Am J Clin Oncol."},{"issue":"5","key":"12142_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1524-4741.2010.00953.x","volume":"16","author":"S Dawood","year":"2010","unstructured":"Dawood S, Gong Y, Broglio K, et al. Trastuzumab in primary inflammatory breast cancer (ibc): high pathological response rates and improved outcome. Breast J. 2010;16(5):529\u201332. https:\/\/doi.org\/10.1111\/j.1524-4741.2010.00953.x (Epub 2010 Jul 6).","journal-title":"Breast J."},{"issue":"10","key":"12142_CR13","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1245\/s10434-017-5952-x","volume":"24","author":"KJ Rosso","year":"2017","unstructured":"Rosso KJ, Tadros AB, Weiss A, et al. Improved locoregional control in a contemporary cohort of nonmetastatic inflammatory breast cancer patients undergoing surgery. Ann Surg Oncol. 2017;24(10):2981\u20138. https:\/\/doi.org\/10.1245\/s10434-017-5952-x (Epub 2017 Aug 1).","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"12142_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333. https:\/\/doi.org\/10.1016\/S1470-2045(10)70207-2.","journal-title":"Lancet Oncol."},{"issue":"4","key":"12142_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297\u2013305. https:\/\/doi.org\/10.1016\/S1470-2045(13)70035-4 (Epub 2013 Mar 11).","journal-title":"Lancet Oncol."},{"issue":"10","key":"12142_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA."},{"issue":"12","key":"12142_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310. https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7 (Epub 2014 Oct 15).","journal-title":"Lancet Oncol."},{"issue":"7","key":"12142_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(13)70166-9 (Epub 2013 May 15).","journal-title":"Lancet Oncol."},{"issue":"3","key":"12142_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201364. https:\/\/doi.org\/10.1200\/JCO.2014.55.7827 (Epub 2014 Dec 1).","journal-title":"J Clin Oncol."},{"issue":"14","key":"12142_CR20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361. https:\/\/doi.org\/10.1001\/jama.2013.278932.","journal-title":"JAMA."},{"key":"12142_CR21","doi-asserted-by":"publisher","unstructured":"O'Toole J, Jammallo LS, Skolny MN, et al. Lymphedema following treatment for breast cancer: a new approach to an old problem. Crit Rev Oncol Hematol. 2013;88(2):437\u201346. doi: https:\/\/doi.org\/10.1016\/j.critrevonc.2013.05.001. Epub 2013 Jun 16. Review.","DOI":"10.1016\/j.critrevonc.2013.05.001"},{"key":"12142_CR22","doi-asserted-by":"publisher","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471\u20134. doi: https:\/\/doi.org\/10.1245\/s10434-010-0985-4.","DOI":"10.1245\/s10434-010-0985-4"},{"key":"12142_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/mhealth-19-218.eCollection2021.Review","volume":"7","author":"LM Havens","year":"2021","unstructured":"Havens LM, Brunelle CL, Gillespie TC, et al. Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital. Mhealth. 2021;7:11. https:\/\/doi.org\/10.21037\/mhealth-19-218.eCollection2021.Review.","journal-title":"Mhealth."},{"issue":"9","key":"12142_CR24","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1245\/s10434-015-4408-4","volume":"22","author":"AT Nguyen","year":"2015","unstructured":"Nguyen AT, Chang EI, Suami H, Chang DW. An algorithmic approach to simultaneous vascularized lymph node transfer with microvascular breast reconstruction. Ann Surg Oncol. 2015;22(9):2919\u201324. https:\/\/doi.org\/10.1245\/s10434-015-4408-4 (Epub 2015 Jan 27).","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"12142_CR25","doi-asserted-by":"publisher","first-page":"676e","DOI":"10.1097\/PRS.0000000000006634","volume":"145","author":"EI Chang","year":"2020","unstructured":"Chang EI, Ibrahim A, Liu J, et al. Optimizing quality of life for patients with breast cancer-related lymphedema: a prospective study combining DIEP flap breast reconstruction and lymphedema surgery. Plast Reconstr Surg. 2020;145(4):676e-e685. https:\/\/doi.org\/10.1097\/PRS.0000000000006634.","journal-title":"Plast Reconstr Surg."},{"key":"12142_CR26","doi-asserted-by":"publisher","unstructured":"Chang EI, Masi\u00e0 J, Smith ML. Combining autologous breast reconstruction and vascularized lymph node transfer. Semin Plast Surg. 2018;32(1):36\u201341. doi: https:\/\/doi.org\/10.1055\/s-0038-1632402. Epub 2018 Apr 9. Review.","DOI":"10.1055\/s-0038-1632402"},{"key":"12142_CR27","doi-asserted-by":"publisher","unstructured":"Schaverien MV, Baumann DP, Selber JC, Chang EI, Hanasono MM, Chu C. Building a multidisciplinary comprehensive academic lymphedema program. Plast Reconstr Surg Glob Open. 2020;8(3):e2670. doi: https:\/\/doi.org\/10.1097\/GOX.0000000000002670. eCollection 2020 Mar.","DOI":"10.1097\/GOX.0000000000002670"},{"issue":"1","key":"12142_CR28","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.clbc.2017.06.014","volume":"18","author":"SM DeSnyder","year":"2018","unstructured":"DeSnyder SM, Mittendorf EA, Le-Petross C, et al. Prospective feasibility trial of sentinel lymph node biopsy in the setting of inflammatory breast cancer. Clin Breast Cancer. 2018;18(1):e73\u20137. https:\/\/doi.org\/10.1016\/j.clbc.2017.06.014 (Epub 2017 Jul 10).","journal-title":"Clin Breast Cancer."},{"issue":"12","key":"12142_CR29","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1245\/s10434-020-08891-y","volume":"27","author":"LM Postlewait","year":"2020","unstructured":"Postlewait LM, Teshome M, DeSnyder SM, et al. Factors associated with pathological node negativity in inflammatory breast cancer: are there patients who may be candidates for a de-escalation of axillary surgery? Ann Surg Oncol. 2020;27(12):4603\u201312. https:\/\/doi.org\/10.1245\/s10434-020-08891-y (Epub 2020 Jul 24).","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"12142_CR30","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1245\/s10434-017-5960-x","volume":"24","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol. 2017;24(10):2972\u201380. https:\/\/doi.org\/10.1245\/s10434-017-5960-x (Epub 2017 Aug 1).","journal-title":"Ann Surg Oncol."},{"key":"12142_CR31","doi-asserted-by":"publisher","unstructured":"Shaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015;65(1):55\u201381. doi:https:\/\/doi.org\/10.3322\/caac.21253. Epub 2014 Nov 19. Review.","DOI":"10.3322\/caac.21253"},{"issue":"9","key":"12142_CR32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/bjs.9846","volume":"102","author":"M Cariati","year":"2015","unstructured":"Cariati M, Bains SK, Grootendorst MR, et al. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema. Br J Surg. 2015;102(9):1071\u20138. https:\/\/doi.org\/10.1002\/bjs.9846 (Epub 2015 Jun 3).","journal-title":"Br J Surg."},{"issue":"10","key":"12142_CR33","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.1998.16.10.3426","volume":"16","author":"K Semb","year":"1998","unstructured":"Semb K, Aamdal S, Oian P. Capillary protein leak syndromes appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol. 1998;16(10):3426\u201332. https:\/\/doi.org\/10.1200\/JCO.1998.16.10.3426.","journal-title":"J Clin Oncol."},{"issue":"1","key":"12142_CR34","first-page":"18","volume":"41","author":"S Hayes","year":"2008","unstructured":"Hayes S, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology. 2008;41(1):18\u201328.","journal-title":"Lymphology."},{"key":"12142_CR35","doi-asserted-by":"publisher","unstructured":"Paramanandam VS, Dylke E, Clark GM, et al. Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer-related lymphedema: a randomized controlled trial. J Clin Oncol. 2022;JCO2102567. doi:https:\/\/doi.org\/10.1200\/JCO.21.02567. [Epub ahead of print]","DOI":"10.1200\/JCO.21.02567"},{"issue":"4","key":"12142_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21037\/gs.2017.11.04.Review","volume":"7","author":"TC Gillespie","year":"2018","unstructured":"Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379\u2013403. https:\/\/doi.org\/10.21037\/gs.2017.11.04.Review.","journal-title":"Gland Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12142-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12142-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12142-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T20:01:20Z","timestamp":1662753680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12142-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["12142"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12142-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Simona Shaitelman discloses the following relationships: Alpha Tau (Contracted research agreement), Artios Pharma, Emerson Collective, Exact Sciences (Contracted research agreement), NIH R21, TAE Life Sciences (Contracted research agreement). Wendy Woodward discloses the following relationships: Exact Sciences (honoraria), DOD (contracted research agreement), Susan G. Komen (contracted research agreement, NIH R-01, Epic Science (honoraria). All other authors have reported no financial disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}